BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 10523695)

  • 1. Most of the patients with cirrhosis in Japan die from hepatocellular carcinoma.
    Kato Y; Hamasaki K; Aritomi T; Nakao K; Nakata K; Eguchi K
    Oncol Rep; 1999; 6(6):1273-6. PubMed ID: 10523695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses.
    Kato Y; Nakata K; Omagari K; Furukawa R; Kusumoto Y; Mori I; Tajima H; Tanioka H; Yano M; Nagataki S
    Cancer; 1994 Oct; 74(8):2234-8. PubMed ID: 7922974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
    Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
    J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
    Fattovich G; Stroffolini T; Zagni I; Donato F
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
    Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
    Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis.
    Tanaka K; Sakai H; Hashizume M; Hirohata T
    Jpn J Cancer Res; 1998 Dec; 89(12):1241-50. PubMed ID: 10081484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
    Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
    Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis.
    Kobayashi M; Ikeda K; Saitoh S; Suzuki F; Tsubota A; Suzuki Y; Arase Y; Murashima N; Chayama K; Kumada H
    Cancer; 2000 Jun; 88(11):2471-7. PubMed ID: 10861422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis.
    Toshikuni N; Izumi A; Nishino K; Inada N; Sakanoue R; Yamato R; Suehiro M; Kawanaka M; Yamada G
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1276-83. PubMed ID: 19486451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia.
    Dondog B; Lise M; Dondov O; Baldandorj B; Franceschi S
    Eur J Cancer Prev; 2011 Jan; 20(1):33-9. PubMed ID: 21166097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon.
    Andoulo FA; Noah DN; Djapa R; Kowo M; Talla P; Medjo EH; Djomkam IK; Nonga BN; Njoya O; Ndam EC
    Pan Afr Med J; 2014; 19():379. PubMed ID: 25977742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
    Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
    Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.